Eton Pharmaceuticals' GAAP loss for 9M 2021 was $2.994 million, down 6.8 times from $20.283 million in the previous year. Revenue was $15.739 million. The company did not generate revenue a year earlier.
Eton Pharmaceuticals' GAAP loss for 9M 2021 was $2.994 million, down 6.8 times from $20.283 million in the previous year. Revenue was $15.739 million. The company did not generate revenue a year earlier. 
ir.etonpharma.com
English (US) 